Position Overview:
Molecular and/or cellular biologist with interest in advancing the field of functional genomics applied to the molecular dissection of disease and disease therapeutics. The role will be within the Translational Sciences Genomics group focused on a diverse therapeutic portfolio within rare disease, neurobiology, gene therapy and immunology. The Translational Sciences Group in Sanofi strives to generate scientific knowledge that translates into transformative therapies for patients with unmet medical needs. Translational Sciences is building a world-class genomics team that is passionate to contribute to the discovery and development of novel therapeutics for patients. The Translational Sciences Genomics team is seeking highly motivated genomics scientists to join the multidisciplinary team to apply functional genomics to multiple disease areas. As a result, the successful candidate would contribute to various drug discovery and development projects for a number of indications of interest to Sanofi. The successful candidate will have the training, knowledge and expertise in the application of advanced approaches on a diverse set of biological samples to generate datasets to develop actionable hypotheses. The successful candidate would have the ability to learn and acquire new techniques and methodologies. The selected candidate is expected to contribute to developing analytical strategies for the identification of novel therapeutic targets, the discovery of predictive biomarkers for patients’ stratification, and analysis of molecular data to define disease and therapeutic molecular mechanisms. This exciting role will afford talented molecular biology or genomics scientists the opportunity to translate their data-generation and analytical abilities into novel actionable hypotheses.
Key Responsibilities:
As a member of multidisciplinary team will apply functional genomics platforms and technologies to a variety of disease and therapeutic models as well as human cell systems.
Provide functional genomics and molecular biology laboratory expertise.
Produce, QC, and interpret genomics data.
Communicate and collaborate with therapeutic collaborators.
Collaborate with other groups in Translational Sciences and Therapeutic Area partners and help the group champion projects from discovery to early clinical development.
Prepare publications, research and clinical/regulatory documentation in accordance with Sanofi quality standards.
Essential Qualifications:
Bachelor’s degree with 6 years of relevant research experience OR Master’s degree with 3 years of relevant research experience OR a PhD in biochemistry, molecular biology, or genomics.
Hands on molecular biology and/or genomics laboratory experience with the ability to largely work independently in the lab.
Team player able to collaborate with multiple project teams.
Preferred Qualifications:
CRISPR and/or siRNA laboratory and design expertise.
miRNA design and testing.
Excellent written and oral communication skills.
Excellent interpersonal and team skills.
Established publication record.
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.